The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Saphris (Asenapine) Market Research Report 2025
Synopsis
The global Saphris (Asenapine) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Saphris (Asenapine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Saphris (Asenapine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Saphris (Asenapine) include Allergan plc (AbbVie Inc.), Merck & Co., Inc. and Actavis Generics (Teva), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Saphris (Asenapine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saphris (Asenapine).
Report Scope
The Saphris (Asenapine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Saphris (Asenapine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saphris (Asenapine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc (AbbVie Inc.)
Merck & Co., Inc.
Actavis Generics (Teva)
Segment by Type
5 mg
10 mg
Segment by Application
Schizophrenia
Acute Mania
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Saphris (Asenapine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Saphris (Asenapine) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Saphris (Asenapine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Saphris (Asenapine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Saphris (Asenapine) include Allergan plc (AbbVie Inc.), Merck & Co., Inc. and Actavis Generics (Teva), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Saphris (Asenapine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saphris (Asenapine).
Report Scope
The Saphris (Asenapine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Saphris (Asenapine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saphris (Asenapine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc (AbbVie Inc.)
Merck & Co., Inc.
Actavis Generics (Teva)
Segment by Type
5 mg
10 mg
Segment by Application
Schizophrenia
Acute Mania
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Saphris (Asenapine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Saphris (Asenapine) Market Overview
1.1 Product Overview and Scope of Saphris (Asenapine)
1.2 Saphris (Asenapine) Segment by Type
1.2.1 Global Saphris (Asenapine) Market Value Comparison by Type (2024-2030)
1.2.2 5 mg
1.2.3 10 mg
1.3 Saphris (Asenapine) Segment by Application
1.3.1 Global Saphris (Asenapine) Market Value by Application: (2024-2030)
1.3.2 Schizophrenia
1.3.3 Acute Mania
1.3.4 Others
1.4 Global Saphris (Asenapine) Market Size Estimates and Forecasts
1.4.1 Global Saphris (Asenapine) Revenue 2019-2030
1.4.2 Global Saphris (Asenapine) Sales 2019-2030
1.4.3 Global Saphris (Asenapine) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Saphris (Asenapine) Market Competition by Manufacturers
2.1 Global Saphris (Asenapine) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Saphris (Asenapine) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Saphris (Asenapine) Average Price by Manufacturers (2019-2024)
2.4 Global Saphris (Asenapine) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Saphris (Asenapine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Saphris (Asenapine), Product Type & Application
2.7 Saphris (Asenapine) Market Competitive Situation and Trends
2.7.1 Saphris (Asenapine) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Saphris (Asenapine) Players Market Share by Revenue
2.7.3 Global Saphris (Asenapine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Saphris (Asenapine) Retrospective Market Scenario by Region
3.1 Global Saphris (Asenapine) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Saphris (Asenapine) Global Saphris (Asenapine) Sales by Region: 2019-2030
3.2.1 Global Saphris (Asenapine) Sales by Region: 2019-2024
3.2.2 Global Saphris (Asenapine) Sales by Region: 2025-2030
3.3 Global Saphris (Asenapine) Global Saphris (Asenapine) Revenue by Region: 2019-2030
3.3.1 Global Saphris (Asenapine) Revenue by Region: 2019-2024
3.3.2 Global Saphris (Asenapine) Revenue by Region: 2025-2030
3.4 North America Saphris (Asenapine) Market Facts & Figures by Country
3.4.1 North America Saphris (Asenapine) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Saphris (Asenapine) Sales by Country (2019-2030)
3.4.3 North America Saphris (Asenapine) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Saphris (Asenapine) Market Facts & Figures by Country
3.5.1 Europe Saphris (Asenapine) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Saphris (Asenapine) Sales by Country (2019-2030)
3.5.3 Europe Saphris (Asenapine) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Saphris (Asenapine) Market Facts & Figures by Country
3.6.1 Asia Pacific Saphris (Asenapine) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Saphris (Asenapine) Sales by Country (2019-2030)
3.6.3 Asia Pacific Saphris (Asenapine) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Saphris (Asenapine) Market Facts & Figures by Country
3.7.1 Latin America Saphris (Asenapine) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Saphris (Asenapine) Sales by Country (2019-2030)
3.7.3 Latin America Saphris (Asenapine) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Saphris (Asenapine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Saphris (Asenapine) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Saphris (Asenapine) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Saphris (Asenapine) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Saphris (Asenapine) Sales by Type (2019-2030)
4.1.1 Global Saphris (Asenapine) Sales by Type (2019-2024)
4.1.2 Global Saphris (Asenapine) Sales by Type (2025-2030)
4.1.3 Global Saphris (Asenapine) Sales Market Share by Type (2019-2030)
4.2 Global Saphris (Asenapine) Revenue by Type (2019-2030)
4.2.1 Global Saphris (Asenapine) Revenue by Type (2019-2024)
4.2.2 Global Saphris (Asenapine) Revenue by Type (2025-2030)
4.2.3 Global Saphris (Asenapine) Revenue Market Share by Type (2019-2030)
4.3 Global Saphris (Asenapine) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Saphris (Asenapine) Sales by Application (2019-2030)
5.1.1 Global Saphris (Asenapine) Sales by Application (2019-2024)
5.1.2 Global Saphris (Asenapine) Sales by Application (2025-2030)
5.1.3 Global Saphris (Asenapine) Sales Market Share by Application (2019-2030)
5.2 Global Saphris (Asenapine) Revenue by Application (2019-2030)
5.2.1 Global Saphris (Asenapine) Revenue by Application (2019-2024)
5.2.2 Global Saphris (Asenapine) Revenue by Application (2025-2030)
5.2.3 Global Saphris (Asenapine) Revenue Market Share by Application (2019-2030)
5.3 Global Saphris (Asenapine) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan plc (AbbVie Inc.)
6.1.1 Allergan plc (AbbVie Inc.) Corporation Information
6.1.2 Allergan plc (AbbVie Inc.) Description and Business Overview
6.1.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio
6.1.5 Allergan plc (AbbVie Inc.) Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporation Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Saphris (Asenapine) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co., Inc. Saphris (Asenapine) Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 Actavis Generics (Teva)
6.3.1 Actavis Generics (Teva) Corporation Information
6.3.2 Actavis Generics (Teva) Description and Business Overview
6.3.3 Actavis Generics (Teva) Saphris (Asenapine) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio
6.3.5 Actavis Generics (Teva) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Saphris (Asenapine) Industry Chain Analysis
7.2 Saphris (Asenapine) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Saphris (Asenapine) Production Mode & Process
7.4 Saphris (Asenapine) Sales and Marketing
7.4.1 Saphris (Asenapine) Sales Channels
7.4.2 Saphris (Asenapine) Distributors
7.5 Saphris (Asenapine) Customers
8 Saphris (Asenapine) Market Dynamics
8.1 Saphris (Asenapine) Industry Trends
8.2 Saphris (Asenapine) Market Drivers
8.3 Saphris (Asenapine) Market Challenges
8.4 Saphris (Asenapine) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Saphris (Asenapine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Saphris (Asenapine) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Saphris (Asenapine) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Saphris (Asenapine) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Saphris (Asenapine) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Saphris (Asenapine) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Saphris (Asenapine) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Saphris (Asenapine) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Saphris (Asenapine), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Saphris (Asenapine), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Saphris (Asenapine), Product Type & Application
Table 12. Global Key Manufacturers of Saphris (Asenapine), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Saphris (Asenapine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saphris (Asenapine) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Saphris (Asenapine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Saphris (Asenapine) Sales by Region (2019-2024) & (K Units)
Table 18. Global Saphris (Asenapine) Sales Market Share by Region (2019-2024)
Table 19. Global Saphris (Asenapine) Sales by Region (2025-2030) & (K Units)
Table 20. Global Saphris (Asenapine) Sales Market Share by Region (2025-2030)
Table 21. Global Saphris (Asenapine) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Saphris (Asenapine) Revenue Market Share by Region (2019-2024)
Table 23. Global Saphris (Asenapine) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Saphris (Asenapine) Revenue Market Share by Region (2025-2030)
Table 25. North America Saphris (Asenapine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Saphris (Asenapine) Sales by Country (2019-2024) & (K Units)
Table 27. North America Saphris (Asenapine) Sales by Country (2025-2030) & (K Units)
Table 28. North America Saphris (Asenapine) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Saphris (Asenapine) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Saphris (Asenapine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Saphris (Asenapine) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Saphris (Asenapine) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Saphris (Asenapine) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Saphris (Asenapine) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Saphris (Asenapine) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Saphris (Asenapine) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Saphris (Asenapine) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Saphris (Asenapine) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Saphris (Asenapine) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Saphris (Asenapine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Saphris (Asenapine) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Saphris (Asenapine) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Saphris (Asenapine) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Saphris (Asenapine) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Saphris (Asenapine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Saphris (Asenapine) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Saphris (Asenapine) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Saphris (Asenapine) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Saphris (Asenapine) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Saphris (Asenapine) Sales (K Units) by Type (2019-2024)
Table 51. Global Saphris (Asenapine) Sales (K Units) by Type (2025-2030)
Table 52. Global Saphris (Asenapine) Sales Market Share by Type (2019-2024)
Table 53. Global Saphris (Asenapine) Sales Market Share by Type (2025-2030)
Table 54. Global Saphris (Asenapine) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Saphris (Asenapine) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Saphris (Asenapine) Revenue Market Share by Type (2019-2024)
Table 57. Global Saphris (Asenapine) Revenue Market Share by Type (2025-2030)
Table 58. Global Saphris (Asenapine) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Saphris (Asenapine) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Saphris (Asenapine) Sales (K Units) by Application (2019-2024)
Table 61. Global Saphris (Asenapine) Sales (K Units) by Application (2025-2030)
Table 62. Global Saphris (Asenapine) Sales Market Share by Application (2019-2024)
Table 63. Global Saphris (Asenapine) Sales Market Share by Application (2025-2030)
Table 64. Global Saphris (Asenapine) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Saphris (Asenapine) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Saphris (Asenapine) Revenue Market Share by Application (2019-2024)
Table 67. Global Saphris (Asenapine) Revenue Market Share by Application (2025-2030)
Table 68. Global Saphris (Asenapine) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Saphris (Asenapine) Price (USD/Unit) by Application (2025-2030)
Table 70. Allergan plc (AbbVie Inc.) Corporation Information
Table 71. Allergan plc (AbbVie Inc.) Description and Business Overview
Table 72. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product
Table 74. Allergan plc (AbbVie Inc.) Recent Developments/Updates
Table 75. Merck & Co., Inc. Corporation Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Saphris (Asenapine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co., Inc. Saphris (Asenapine) Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. Actavis Generics (Teva) Corporation Information
Table 81. Actavis Generics (Teva) Description and Business Overview
Table 82. Actavis Generics (Teva) Saphris (Asenapine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Actavis Generics (Teva) Saphris (Asenapine) Product
Table 84. Actavis Generics (Teva) Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Saphris (Asenapine) Distributors List
Table 88. Saphris (Asenapine) Customers List
Table 89. Saphris (Asenapine) Market Trends
Table 90. Saphris (Asenapine) Market Drivers
Table 91. Saphris (Asenapine) Market Challenges
Table 92. Saphris (Asenapine) Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Saphris (Asenapine)
Figure 2. Global Saphris (Asenapine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Saphris (Asenapine) Market Share by Type in 2023 & 2030
Figure 4. 5 mg Product Picture
Figure 5. 10 mg Product Picture
Figure 6. Global Saphris (Asenapine) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Saphris (Asenapine) Market Share by Application in 2023 & 2030
Figure 8. Schizophrenia
Figure 9. Acute Mania
Figure 10. Others
Figure 11. Global Saphris (Asenapine) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Saphris (Asenapine) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Saphris (Asenapine) Sales (2019-2030) & (K Units)
Figure 14. Global Saphris (Asenapine) Average Price (USD/Unit) & (2019-2030)
Figure 15. Saphris (Asenapine) Report Years Considered
Figure 16. Saphris (Asenapine) Sales Share by Manufacturers in 2023
Figure 17. Global Saphris (Asenapine) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Saphris (Asenapine) Players: Market Share by Revenue in 2023
Figure 19. Saphris (Asenapine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Saphris (Asenapine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Saphris (Asenapine) Sales Market Share by Country (2019-2030)
Figure 22. North America Saphris (Asenapine) Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Saphris (Asenapine) Sales Market Share by Country (2019-2030)
Figure 26. Europe Saphris (Asenapine) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Saphris (Asenapine) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Saphris (Asenapine) Revenue Market Share by Region (2019-2030)
Figure 34. China Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Saphris (Asenapine) Sales Market Share by Country (2019-2030)
Figure 45. Latin America Saphris (Asenapine) Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Saphris (Asenapine) Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Saphris (Asenapine) Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Saphris (Asenapine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Saphris (Asenapine) by Type (2019-2030)
Figure 55. Global Revenue Market Share of Saphris (Asenapine) by Type (2019-2030)
Figure 56. Global Saphris (Asenapine) Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Saphris (Asenapine) by Application (2019-2030)
Figure 58. Global Revenue Market Share of Saphris (Asenapine) by Application (2019-2030)
Figure 59. Global Saphris (Asenapine) Price (USD/Unit) by Application (2019-2030)
Figure 60. Saphris (Asenapine) Value Chain
Figure 61. Saphris (Asenapine) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
